MARKET

ACIU

ACIU

AC Immune
NASDAQ
2.450
+0.030
+1.24%
Opening 10:48 04/18 EDT
OPEN
2.410
PREV CLOSE
2.420
HIGH
2.480
LOW
2.360
VOLUME
10.49K
TURNOVER
0
52 WEEK HIGH
5.14
52 WEEK LOW
1.780
MARKET CAP
242.30M
P/E (TTM)
-3.2207
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ACIU last week (0408-0412)?
Weekly Report · 3d ago
Weekly Report: what happened at ACIU last week (0401-0405)?
Weekly Report · 04/08 11:54
CALM,PLAY and VNDA are among after hour movers
On the Move CALM, PLAY and VNDA are among after hour movers. Sight Sciences (SGHT) and Cal-Maine Foods (CALM) gain. Acorda Therapeutics (ACOR) and Dave & Buster's Entertainment (PLAY) are losers.
Seeking Alpha · 04/02 20:43
Weekly Report: what happened at ACIU last week (0325-0329)?
Weekly Report · 04/01 11:51
Weekly Report: what happened at ACIU last week (0318-0322)?
Weekly Report · 03/25 11:54
Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Fulcrum Therapeutics (FULC) and AC Immune SA (ACIU)
TipRanks · 03/19 05:50
Weekly Report: what happened at ACIU last week (0311-0315)?
Weekly Report · 03/18 11:52
AC Immune Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Dow Jones · 03/15 10:52
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.